Partners

MDS Nordion engages in commercial collaborations aimed at improving the health and well-being of people worldwide.

Macrocyclics

MDS Nordion is collaborating with Macrocyclics Inc., a privately held, Dallas, Texas-based company that conducts research and development, good manufacturing practices (GMP), synthesis, and makes accessible to the research community a variety of high purity ligands for nuclear medicine and magnetic resonance imaging applications.

The collaboration is focused on the development of innovative, bifunctional chelates for use in molecular imaging and targeted therapeutic pharmaceuticals. Bifunctional chelates are chemical compounds used to secure a radioisotope to a molecular targeting agent such as a monoclonal antibody, peptide, or other molecules specific for biologic receptors. The use of molecular targeting molecules is an established and increasingly promising technique that has the potential to significantly improve the ability to diagnose and treat disease, including cancer.

An outcome of this collaboration is the filing of patents covering innovative bifunctional chelates. We anticipate additional innovations arising from this collaboration.